A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk
By N. Bouatia-Naji, A. Bonnefond, Christine Cavalcanti-Proença, T. Sparsø, J. Holmkvist, Marion Marchand, J. Delplanque, S. Lobbens, G. Rocheleau, E. Durand and 31 more. Nature Genetics, 2009
618 citations recorded by the source corpus.
Subfields: Endocrine and Autonomic Systems, Endocrinology, Diabetes and Metabolism, Genetics
View Paper: https://www.semanticscholar.org/paper/b1b6d3fcf9555183daca967c814aba1fb3c1632c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrine and Autonomic Systems
In Endocrinology, Diabetes and Metabolism
- Elizabeth T. Cirulli
- David B. Goldstein
- F. B. Hu
- Oluf Pedersen
- Mark I. McCarthy
- E. Ford
- I. Graham
- F. B. Hu
In Genetics
- Gonçalo R. Abecasis
- Mark J. Daly
- Cristen J. Willer
- Yurii S. Aulchenko
- David Altshuler
- Elizabeth T. Cirulli
- Michael Boehnke
- David B. Goldstein
Citations in the corpus
- Human genetic variation and its contribution to complex traits (2009, background): “For example, the genetic propensity to develop type 2 diabetes (T2D) seems to involve genes in several different pathways that affect pancreatic β-cell formation and function, as well as pathways affecting fasting glucose levels and obesit”
- Uncovering the roles of rare variants in common disease through whole-genome sequencing (2010, methodology): “This assumption has controlled much of the follow-up research, in which the focus has generally been on resequencing in the linkage disequilibrium block defined by common variant”
- Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis (2010, background): “Fourteen signals reaching genome-wide significance Two of the 14 signals reaching genome-wide significance on joint analysis (those near MTNR1B and IRS1 ) represent loci for which T2D associations have been recently reported in samples which partially overlap with those studied her”
- Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus (2016, background): “A possible link between circadian clocks, regulation of glucose metabolism, and melatonin signaling in the pancreas was indicated by genetic studies (255).”
- Melatonin--a pleiotropic, orchestrating regulator molecule. (2011, background): “The human MT2 polymorphisms associated with increased risk for developing diabetes type 2 (Staiger et al., 2008; Bouatia-Naji et al., 2009; Lyssenko et al., 2009; Shieh et al., 2009; Sparsø et al., 2009; Liu et al., 2010) may be interpreted in this context.”
- International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, Classification, and Pharmacology of G Protein-Coupled Melatonin Receptors (2010, background): “sons with genetic variations in the MTNR1B gene encoding the MT2 melatonin receptor (Bouatia-Naji et al., 2009; Lyssenko et al., 2009; Prokopenko et al., 2009).”
- The mammalian circadian timing system: organization and coordination of central and peripheral clocks. (2010, background): “Genetic studies in humans have revealed a possible link between MTNR1B allele variants and hyperglycemia, impaired earlyphase insulin secretion, and β-cell function (258, 259).”